Hamatani, Yasuhiro
Ogawa, Hisashi
Takabayashi, Kensuke
Yamashita, Yugo
Takagi, Daisuke
Esato, Masahiro
Chun, Yeong-Hwa
Tsuji, Hikari
Wada, Hiromichi
Hasegawa, Koji
Abe, Mitsuru
Lip, Gregory Y. H.
Akao, Masaharu
Article History
Received: 7 April 2016
Accepted: 12 July 2016
First Online: 3 August 2016
Competing interests
: Dr. Akao received lecture fees from Pfizer, Bristol Myers Squibb, Boehringer Ingelheim, Bayer Healthcare and Daiichi-Sankyo. Dr Lip has served as a consultant or advisory board for Bayer/ Janssen, Astellas, Merck, Sanofi, BMS/Pfizer, Biotronik, Medtronic, Portola, Boehringer Ingelheim, Microlife and Daiichi-Sankyo and has been on the speakers bureau for Bayer, BMS/Pfizer, Medtronic, Boehringer Ingelheim, Microlife, Roche and Daiichi-Sankyo. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.